Physician profile
Deepak Joshi
NPI 1154506582
$2,698.35
in general payments reported to CMS, 2019-2025
12 companies · $548 in 2025
The $548 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $220 · 2021: $274 · 2022: $121 · 2023: $165 · 2024: $1,121 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,334 · Food and Beverage: $480 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,333.51 |
| Food and Beverage | $480.42 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,687.18 | 2022-2025 | Linq II |
| Novartis Pharmaceuticals Corporation | $384.12 | 2019-2024 | |
| Pfizer INC. | $221.77 | 2019-2023 | |
| Amarin Pharma, INC. | $150.39 | 2019-2021 | |
| Boston Scientific Corporation | $74.89 | 2019-2021 | |
| Amgen INC. | $56.59 | 2020-2023 | Repatha |
| Merck Sharp & Dohme LLC | $38.59 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2024 | |
| Tactile Systems Technology INC | $19.60 | 2023 | Entre Plus, Flexitouch Plus |
| Sanofi-Aventis U.S. LLC | $16.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.27 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.